PLoS GeneticsGeneticsPeer-reviewed journal article
Predicting the functional effect of compound heterozygous genotypes from large scale variant effect maps
Michael J. XieiD, Gareth A. CromieiD, Katherine L. OwensiD, Martin S. TimouriD, Michelle TangiD, J. Nathan KutziD, Ayman W. El‐HattabiD, Richard N. McLaughliniD, Aimée M. DudleyiD
Abstract
BackgroundPathogenic variants in PHGDH, PSAT1, and PSPH cause a set of rare, autosomal recessive diseases known as serine biosynthesis defects. Serine biosynthesis defects present in a broad phenotypic spectrum that includes, at the severe end, Neu-Laxova syndrome, a lethal multiple congenital anomaly disease, intermediately in the form of infantile serine biosynthesis defects with severe neurological manifestations and growth deficiency, and at the mild end, as childhood disease with intellectual disability. However, because L-serine supplementation, especially if started early, can ameliorate and in some cases even prevent symptoms, knowledge of pathogenic variants is highly actionable. MethodsRecently, our laboratory established a yeast-based assay for human PSAT1 function. We have now applied it at scale to assay the functional impact of 1,914 SNV-accessible amino acid substitutions. In addition to assaying the functional impact of individual variants in yeast haploid cells, we can assay pairwise combinations of PSAT1 alleles that recapitulate human genotypes, including compound heterozygotes, in yeast diploids. ResultsResults of our assays of individual variants (in haploid yeast cells) agree well with clinical interpretations and protein structure-function relationships, supporting the use of our data as functional evidence under the ACMG interpretation guidelines. Results from our diploid assay successfully distinguish patient genotypes from those of healthy carriers and agree well with disease severity. Finally, we present a linear model that uses individual allele measurements (in haploid yeast cells) to accurately predict the biallelic function (in diploid yeast cells) of ~1.8 million allele combinations corresponding to potential human genotypes. ConclusionsTaken together, our work provides an example of how large-scale functional assays in model systems can be powerfully applied to the study of a rare disease.
- Citations
- 6
- FWCI
- 0.99
- Field percentile
- top 25%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Cell-Based Assay to Categorize Variants of Human Succinate Semialdehyde Dehydrogenase Associated with Autism Spectrum Disorder
Barry P. Young, Isaac Robinson, … Christopher J. R. Loewen·bioRxiv·Jan 16, 2026
- A proactive genotype-to-patient-phenotype map for cystathionine beta-synthase
Song Sun, Jochen Weile, … Frederick P. Roth·Genome MedicinePeer-reviewed·Jan 30, 2020
- Landscapes of missense variant impact for human superoxide dismutase 1
Anna Axakova, M. Ding, … Frederick P. Roth·The American Journal of Human GeneticsPeer-reviewed·Sep 16, 2025
- A humanized yeast model for studying TRAPP complex mutations; proof-of-concept using variants from an individual with a TRAPPC1-associated neurodevelopmental syndrome
Erta Zykaj, Chelsea Abboud, … Michael G. Sacher·CellsPeer-reviewed·Aug 30, 2024
- Comprehensive assessment of recessive, pathogenic AARS1 alleles in a humanized yeast model reveals loss-of-function and dominant-negative effects
Molly E. Kuo, Maclaine Parish, … Anthony Antonellis·bioRxiv·Jun 20, 2024
- Functional Profiling of 2,193 ASS1 Missense Variants: Insights into Variant Pathogenicity and Epistatic Interactions in Citrullinemia Type I
Russell S. Lo, Gareth A. Cromie, … Aimée M. Dudley·PLoS GeneticsPeer-reviewed·Jun 17, 2026